Fatigue Clinical Trial
Official title:
Evaluation and Diagnosis of Potential Research Subjects With Pain and Fatigue Syndromes
Verified date | September 2020 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will examine people who have pain or fatigue symptoms with a known or unknown
diagnosis to determine eligibility for other research studies. No treatment is offered under
this protocol.
People 18 years of age or older with symptoms of pain and fatigue may be eligible for this
study. Participants undergo standard examinations needed to diagnose or evaluate their
symptoms. The results of the test are used to screen subjects for possible participation in
other Nursing Institute studies. The study requires from one to three visits at NIH over 12
months for procedures that may include the following:
- Medical history, physical examination and questionnaires related to symptoms and quality
of life.
- Blood tests
- Electrocardiogram
- Tender point testing. Pressure is applied to areas of the shoulder, hip, neck, chest,
elbow and knee to identify tenderness.
Status | Completed |
Enrollment | 367 |
Est. completion date | September 17, 2020 |
Est. primary completion date | September 17, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
- INCLUSION CRITERIA: To be included, patients must meet all of the following: - Are greater than or equal to 18 years of age; - Have symptoms of pain and/or fatigue. EXCLUSION CRITERIA: Patients with any one of the following will be excluded: - Inability to provide informed consent for the study; - Are unwilling or unable to cooperate with the study procedures or travel to NIH for the procedures. In addition to the above criteria, participants with the following conditions will be excluded from the participating in the peak exercise testing: - Pregnant or lactating women. - Unable to refrain from smoking at least 4 hours prior to exercise testing sessions. - Any medical condition that limits exercise performance and/or affects participants safety during exercise. This includes diseases of the cardiovascular, pulmonary, neurological, metabolic or musculoskeletal systems such as: - Diagnosis or history of ischemic heart disease - Dilated or hypertrophic cardiomyopathy - Non-idiopathic cardiomyopathy - Uncontrolled hypertension, defined as a resting blood pressure above 140/90 mmHg - Diagnosis or history of right or left-sided heart failure or pulmonary hypertension - Diagnosis or history of restrictive or obstructive lung disease - Diagnosis or history of stroke - Uncontrolled Type I or Type II Diabetes Mellitus - Diagnosis of chronic liver disease, chronic kidney disease, acute kidney injury or acute liver failure - Metastatic cancer active within the previous five years - Mitochondrial disease - On medications that would influence aerobic capacity or treadmill performance such as beta-blockers or antiretroviral therapy - Active substance abuse including ETOH - Medical or psychological instability such that subjects could not reasonably be expected to fulfill the study requirements |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Nursing Research (NINR) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Eligibility for participation in NINR study | Qualification for an active NINR study. | screening visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04959214 -
The Effect Of Progressıve Relaxatıon Exercıses
|
N/A | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Completed |
NCT04531891 -
Utility and Validity of a High-intensity, Intermittent Exercise Protocol
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT04960865 -
Kinesio Taping and Calf Muscle Fatigue
|
N/A | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT06421233 -
The Effect of Endorphin Massage Applied to Postpartum Women on Anxiety and Fatigue Levels
|
N/A | |
Active, not recruiting |
NCT05344183 -
Immediate and Short-term Effects of Low-level Laser
|
N/A | |
Completed |
NCT04716049 -
Effectiveness of Recovery Protocols in Elite Professional Young Soccer Players
|
N/A | |
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05241405 -
Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast Cancer
|
N/A | |
Active, not recruiting |
NCT06074627 -
Radicle Energy2: A Study of Health and Wellness Products on Fatigue and Other Health Outcomes
|
N/A | |
Completed |
NCT03943212 -
The Effect of Blood Flow Rate on Dialysis Recovery Time in Patients Undergoing Maintenance Hemodialysis
|
N/A | |
Recruiting |
NCT05567653 -
Effects of Probiotics on Gut Microbiota, Endocannabinoid and Immune Activation and Symptoms of Fatigue in Dancers
|
N/A | |
Active, not recruiting |
NCT05636696 -
COMPANION: A Couple Intervention Targeting Cancer-related Fatigue
|
N/A | |
Not yet recruiting |
NCT05863897 -
e-COGRAT: A Blended eHealth Intervention for Fatigue Following Acquired Brain Injury
|
N/A | |
Not yet recruiting |
NCT05002894 -
Effect of Pilates Exercises On Fatigue In Post Menopausal Women
|
N/A | |
Recruiting |
NCT04091789 -
Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea
|
Phase 2 | |
Completed |
NCT02911649 -
Reducing Sedentary Behaviour With Technology
|
N/A | |
Completed |
NCT03216616 -
Guided Self-Management Intervention Targeting Fatigue in Rheumatic Inflammatory Diseases
|
N/A |